Evaluation of Long-term Outcomes and Toxicity after Stereotactic Phosphorus-32 Based Intracavitary Brachytherapy in Patients with Cystic Craniopharyngioma
Phosphorus-32-based interstitial brachytherapy has an established role as a minimally invasive treatment modality for patients with cystic craniopharyngioma. However, reporting on long-term outcomes with toxicity profiles for large cohorts is lacking in the literature. The purpose of this study is therefore to evaluate the long-term visual, endocrine and neurocognitive function in what is the largest patient series having received this treatment to date.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Xin Yu, Sebastian M Christ, Rui Liu, Yaming Wang, Chenhao Hu, Bo Feng, Anand Mahadevan, Ekkehard M Kasper Source Type: research
More News: Biology | Brachytherapy | Brain | Cancer & Oncology | Craniopharyngioma | Neurology | Phosphorus | Physics | Radiology | Study | Toxicology